Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Trends in Invasive Infection with Methicillin-Resistant Staphylococcus aureus, Connecticut, USA, 2001–2010
|MRSA category and PFGE type||2005||2006||2007||2008||2009||2010||Incidence difference, 2005–2010|
|% C strain‡||27.8||46.7||30.0||62.5||68.8||56.3|
|C strain incidence||0.90||1.57||1.06||2.21||2.39||1.73||+0.83|
|H strain incidence||2.35||1.79||2.47||1.33||1.08||1.35||−1.00|
|% C strain||4.0||8.9||6.7||10.7||14.5||15.2|
|C strain incidence||0.97||1.93||1.52||2.06||2.62||2.87||+1.90|
|H strain incidence||23.19||19.85||21.02||17.21||15.51||16.08||−7.11|
*MRSA, methicillin-resistant Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis; CA, community associated; C strain, community-related strain; H strain , health care–related strain; HA, health care–associated (combined hospital-associated community onset and hospital onset).
†Incidence per 100,000 population.
‡Percentage based on isolate testing shown in Table 3.
- Page created: May 15, 2012
- Page last updated: May 15, 2012
- Page last reviewed: May 15, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)